Meeting
2021 ASCO Annual Meeting
Analysis of patterns of care and benefit of thoracic radiotherapy for patients with stage IV NSCLC in the immunotherapy-era from a national hospital-based registry.
Authors
Michael Kharouta
University Hospitals, Case Medical Center - Seidman Cancer Center, Cleveland, OH
Michael Kharouta , Andrew Jonathan Gross , Kevin Kelley , Serah Choi , Tithi Biswas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9123)
DOI
10.1200/JCO.2021.39.15_suppl.9123
Abstract #
9123
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Real-world study of treatment patterns and clinical outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) post-approval of immunotherapy in the community oncology setting.
First Author: Alexander I. Spira
Poster
2023 ASCO Annual Meeting
Real-world testing and treatment patterns among patients with stage IV non-small cell lung cancer: A retrospective observational study.
First Author: Jeffrey A. Scott
Poster
2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Real-world outcomes for metastatic non-small cell lung cancer patients treated with checkpoint inhibitor immunotherapy in Canada.
First Author: Dimas Yusuf
Poster
2017 ASCO Annual Meeting
Response to single-agent (SA) chemotherapy (CTx) after immunotherapy exposure in non-small cell lung cancer (NSCLC).
First Author: Gustavo Schvartsman